The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy

被引:135
作者
Sifuentes-Franco, Sonia [1 ]
Paul Pacheco-Moises, Fermin [2 ]
Daniel Rodriguez-Carrizalez, Adolfo [1 ]
Guillermina Miranda-Diaz, Alejandra [1 ]
机构
[1] Univ Guadalajara, Univ Hlth Sci Ctr, Dept Physiol, Inst Expt & Clin Therapeut, Guadalajara, Jalisco, Mexico
[2] Univ Guadalajara, Univ Ctr Exact & Engn Sci, Dept Chem, Guadalajara, Jalisco, Mexico
关键词
ENDOPLASMIC-RETICULUM STRESS; GLYCATION END-PRODUCTS; CYTOCHROME-C RELEASE; ALPHA-LIPOIC ACID; NITRIC-OXIDE; ALDOSE REDUCTASE; ANTIOXIDANT TREATMENT; PERIPHERAL NEUROPATHY; THERAPEUTIC TARGETS; ROSEMARY EXTRACTS;
D O I
10.1155/2017/1673081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic polyneuropathy (DPN) is the most frequent and prevalent chronic complication of diabetes mellitus (DM). The state of persistent hyperglycemia leads to an increase in the production of cytosolic and mitochondrial reactive oxygen species (ROS) and favors deregulation of the antioxidant defenses that are capable of activating diverse metabolic pathways which trigger the presence of nitro-oxidative stress (NOS) and endoplasmic reticulum stress. Hyperglycemia provokes the appearance of micro-and macrovascular complications and favors oxidative damage to the macromolecules (lipids, carbohydrates, and proteins) with an increase in products that damage the DNA. Hyperglycemia produces mitochondrial dysfunction with deregulation between mitochondrial fission/fusion and regulatory factors. Mitochondrial fission appears early in diabetic neuropathy with the ability to facilitate mitochondrial fragmentation. Autophagy is a catabolic process induced by oxidative stress that involves the formation of vesicles by the lysosomes. Autophagy protects cells from diverse stress factors and routine deterioration. Clarification of the mechanisms involved in the appearance of complications in DM will facilitate the selection of specific therapeutic options based on the mechanisms involved in the metabolic pathways affected. Nowadays, the antioxidant agents consumed exogenously form an adjuvant therapeutic alternative in chronic degenerative metabolic diseases, such as DM.
引用
收藏
页数:15
相关论文
共 150 条
[11]   Dose-proportionality of oral thioctic acid -: coincidence of assessments via pooled plasma and individual data [J].
Breithaupt-Grögler, K ;
Niebch, G ;
Schneider, E ;
Erb, K ;
Hermann, R ;
Blume, HH ;
Schug, BS ;
Belz, GG .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 8 (01) :57-65
[12]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[13]   Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin [J].
Burkart, V ;
Wang, ZQ ;
Radons, J ;
Heller, B ;
Herceg, Z ;
Stingl, L ;
Wagner, EF ;
Kolb, H .
NATURE MEDICINE, 1999, 5 (03) :314-319
[14]   The vascular NAD(P)H oxidases as therapeutic targets cardiovascular diseases [J].
Cai, H ;
Griendling, KK ;
Harrison, DG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) :471-478
[15]   New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy [J].
Ceriello, A .
DIABETES CARE, 2003, 26 (05) :1589-1596
[16]   Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes [J].
Ceriello, Antonio ;
Testa, Roberto .
DIABETES CARE, 2009, 32 :S232-S236
[17]   Mitochondria: Dynamic organelles in disease, aging, and development [J].
Chan, David C. .
CELL, 2006, 125 (07) :1241-1252
[18]   The regulation of autophagy - unanswered questions [J].
Chen, Yongqiang ;
Klionsky, Daniel J. .
JOURNAL OF CELL SCIENCE, 2011, 124 (02) :161-170
[19]   The interplay between central metabolism and innate immune responses [J].
Cheng, Shih-Chin ;
Joosten, Leo A. B. ;
Netea, Mihai G. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2014, 25 (06) :707-713
[20]   Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve [J].
Coppey, LJ ;
Gellett, JS ;
Davidson, EP ;
Dunlap, JA ;
Lund, DD ;
Yorek, MA .
DIABETES, 2001, 50 (08) :1927-1937